Investments to create a more resilient medicines supply chain and prepare for future public health emergencies are among key provisions of the mammoth $1.7 trillion, bipartisan government appropriations bill signed in

The World Health Organization (WHO) recently issued a Medical Product Alert after four substandard products were identified in The Gambia, which may be linked to t

Revised on: January 17, 2023

Quality should be built into the entire drug product lifecycle – including the manufacturing and production process – to help protect patient safety and build trust in medicines. The same is true for compounded medicines.